Le Moing V - Search Results

1

Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects.

Portales P, Guerrier T, Clot J, Corbeau P, Mettling C, Lin YL, Baillat V, de Boever CM, Le Moing V, Tramoni C, Reynes J, Segondy M. Portales P, et al. Among authors: le moing v. Clin Nutr. 2004 Oct;23(5):1244-5. doi: 10.1016/j.clnu.2004.07.021. Clin Nutr. 2004. PMID: 15380918 No abstract available.

2

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients.

Le Moing V, Peytavin G, Journot V, Cottalorda J, Bouvet E, Chêne G, Préau M, de Boever CM, Leport C, Raffi F; Antiprotease Cohort (APROCO) Study Group. Le Moing V, et al. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):497-9. doi: 10.1097/00126334-200312150-00008. J Acquir Immune Defic Syndr. 2003. PMID: 14657760

3

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists.

Vincent T, Portales P, Baillat V, de Boever CM, Le Moing V, Vidal M, Ducos J, Clot J, Reynes J, Corbeau P. Vincent T, et al. Among authors: le moing v. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):305-9. J Acquir Immune Defic Syndr. 2005. PMID: 15735449

4

CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

Lin YL, Portales P, Segondy M, Baillat V, de Boever CM, Le Moing V, Réant B, Montes B, Clot J, Reynes J, Corbeau P. Lin YL, et al. Among authors: le moing v. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6. J Acquir Immune Defic Syndr. 2005. PMID: 16044003

5

Fulminant varicella hepatitis in a human immunodeficiency virus infected patient: case report and review of the literature.

Lechiche C, Le Moing V, François Perrigault P, Reynes J. Lechiche C, et al. Among authors: le moing v. Scand J Infect Dis. 2006;38(10):929-31. doi: 10.1080/00365540600561785. Scand J Infect Dis. 2006. PMID: 17008242 Review.

6

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

HIV-CAUSAL Collaboration; Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA. HIV-CAUSAL Collaboration, et al. AIDS. 2010 Jan 2;24(1):123-37. doi: 10.1097/QAD.0b013e3283324283. AIDS. 2010. PMID: 19770621 Free PMC article.

7

Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer.

Makinson A, Pujol JL, Le Moing V, Peyriere H, Reynes J. Makinson A, et al. Among authors: le moing v. J Thorac Oncol. 2010 Apr;5(4):562-71. doi: 10.1097/JTO.0b013e3181d3ccf2. J Thorac Oncol. 2010. PMID: 20195169 Free article. Review.

8

Lung cancer: an emerging epidemic in the human immunodeficiency virus-infected population.

Makinson A, Pujol JL, Le Moing V, Reynes J. Makinson A, et al. Among authors: le moing v. J Thorac Oncol. 2010 Nov;5(11):1721-3. doi: 10.1097/JTO.0b013e3181f7c78f. J Thorac Oncol. 2010. PMID: 20975371 Free article. No abstract available.

9

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.

10

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?

Krastinova E, Seng R, Lechenadec J, Panjo H, Essat A, Makhloufi D, Obadia M, Bernard L, Goujard C, Meyer L; ANRS PRIMO cohort. Krastinova E, et al. BMC Infect Dis. 2015 Apr 10;15:178. doi: 10.1186/s12879-015-0892-1. BMC Infect Dis. 2015. PMID: 25888386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters